Francis S. Kim, MD, has been recognized as a 2024 Marquis Who’s Who Top Doctor for his outstanding work in the diagnosis and treatment of autoimmune diseases.
Patients with autoimmune diseases suffer from overactive immune responses that lead to damage of healthy cells in the body.
Dr. Kim is dedicated to evidence-based medical care and scientific research aimed at better understanding the underlying mechanisms of disease.
His work is aimed at developing innovative therapies to address the unmet needs of such patients.
His scientific background, clinical expertise, and patient-focused care have set high standards in the healthcare field.
Dr. Kim was inspired to develop innovative therapies for autoimmune diseases when he realized that only a subset of patients are able to achieve clinical remission.
He did his undergraduate and master’s thesis in areas related to stem cell research in such diseases.
Dr. Kim actively leads research and clinical trials aiming to bring about novel therapies like CAR T cell therapy for such patients.
For just under two years, he has served as Global Medical Director of Clinical Development at Kyverna Therapeutics.
In the next five years, Dr. Kim hopes to successfully develop safe and effective therapies for autoimmune diseases to help improve patients’ quality of life.